MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Novo-Nordisk A/S (NVO) Earnings Date & Reports

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

A.I. Advisor
published Earnings

NVO is expected to report earnings to fall 12.62% to 89 cents per share on May 06

Novo-Nordisk A/S NVO Stock Earnings Reports
Q1'26
Est.
$0.89
Q4'25
Beat
by $0.10
Q3'25
Missed
by $0.09
Q2'25
Est.
$0.93
Q1'25
Beat
by $5.64
The last earnings report on February 03 showed earnings per share of $1.02, beating the estimate of 92 cents. With 11.40M shares outstanding, the current market capitalization sits at 164.82B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NVO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVO showed earnings on February 03, 2026. You can read more about the earnings report here.
View AI-Driven Trading for NVO
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com